Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stress and Inflammation in Late Life Depression
NCT02389465Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Aug 2014
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of celecoxib in major depressive disorder (MDD), sponsored by University of Pennsylvania. Started Aug 2014; status: completed.
02
Drugs
celecoxib
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02389465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02389465.